CIENCIASMEDICASNEWS: Medical News | Medical Articles: Recombinant Antibody Production Services

miércoles, 2 de septiembre de 2020

Medical News | Medical Articles: Recombinant Antibody Production Services

	Antibodies
	The latest antibodies news from News Medical

Recombinant Antibody Production Services

Sino Biological offers comprehensive recombinant expression services to clients in the biomedical industry from gene synthesis to the final products. With more than 10 years of recombinant production history, Sino Biological possesses enriched experience in mammalian cell expression systems.

Find Out More

			Study reveals protective potential of all three major immunoglobulin isotypes against SARS-CoV-2 In a recent medRxiv preprint paper, researchers from Mount Sinai in New York showed that all three major immunoglobulin isotypes (IgM, IgG, and IgA) produced by our immune cells were capable of mediating neutralization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, neutralization titers correlated much better with binding levels of IgM and IgA1 than IgG.

			Study uncovers how the immune system generates effective antibodies An in-depth Garvan study of how the immune system generates effective antibodies provides new insights for vaccine design.

	Monoclonal antibodies may be a better choice than convalescent plasma for treating COVID-19 A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma.

	Unique antibody profile differentiates people with non-celiac gluten sensitivity A new study of the antibodies produced by people with gluten sensitivity may lead to a better way to detect the condition and treat it.

	Researchers develop advanced imaging technique to visualize effects of valencies on B cell responses Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.